HIGH GRADE SEROUS OVARIAN CARCINOMA

This adverse event was reported 19 times

These drugs are most commonly taken by patients reporting HIGH GRADE SEROUS OVARIAN CARCINOMA:

# Drug Count
0 BEVACIZUMAB 13
1 MIRVETUXIMAB SORAVTANSINE 10
2 CARBOPLATIN 9
3 PACLITAXEL 7
4 PACLITAXEL (AIBUMIN-BOUND) 7
5 DOXORUBICIN 6
6 GEMCITABINE 6
7 GEMCITABINE HYDROCHLORIDE 6
8 TRABECTEDIN 6
9 DOXORUBICIN HYDROCHLORIDE 4
See all common drugs associated with HIGH GRADE SEROUS OVARIAN CARCINOMA

HIGH GRADE SEROUS OVARIAN CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MIRVETUXIMAB SORAVTANSINE 10 0.0055
1 TRABECTEDIN 6 0.0026
2 NIRAPARIB 4 0.0002
3 DOXORUBICIN HYDROCHLORIDE 4 0.0001
4 GEMCITABINE HYDROCHLORIDE 6 0.0001
5 BEVACIZUMAB 13 0.0001
6 OLAPARIB 2 0.0001
7 PREDNISOLONE ACETATE 1 0.0001
8 CARBOPLATIN 9 0.0001
9 PACLITAXEL 7 0.0001
See all drugs enriched for association with HIGH GRADE SEROUS OVARIAN CARCINOMA